TY - JOUR
T1 - Challenges in the Care of Patients with AKI Receiving Outpatient Dialysis
T2 - AKINow Recovery Workgroup Report
AU - Neyra, Javier A.
AU - Gewin, Leslie
AU - Ng, Jia H.
AU - Barreto, Erin F.
AU - Freshly, Bonnie
AU - Willett, Jeff
AU - Abdel-Rahman, Emaad M.
AU - Mccoy, Ian
AU - Kwong, Yuenting D.
AU - Silver, Samuel A.
AU - Cerda, Jorge
AU - Vijayan, Anitha
N1 - Publisher Copyright:
Copyright © 2023 The Author(s).
PY - 2024/2/1
Y1 - 2024/2/1
N2 - Background Up to one third of survivors of AKI that required dialysis (AKI-D) during hospitalization remain dialysis dependent at hospital discharge. Of these, 20%-60%, depending on the clinical setting, eventually recover enough kidney function to stop dialysis, and the remainder progress to ESKD. Methods To describe the challenges facing those still receiving dialysis on discharge, the AKINow Committee conducted a group discussion comprising 59 participants, including physicians, advanced practitioners, nurses, pharmacists, and patients. The discussion was framed by a patient who described gaps in care delivery at different transition points and miscommunication between care team members and the patient. Results Group discussions collected patient perspectives of (1) being often scared and uncertain about what is happening to and around them and (2) the importance of effective and timely communication, a comfortable physical setting, and attentive and caring health care providers for a quality health care experience. Provider perspectives included (1) the recognition of the lack of evidence-based practices and quality indicators, the significant variability in current care models, and the uncertain reimbursement incentives focused on kidney recovery and (2) the urgency to address communication barriers among hospital providers and outpatient facilities. Conclusions The workgroup identified key areas for future research and policy change to (1) improve communication among hospital providers, dialysis units, and patients/care partners; (2) develop tools for risk classification, subphenotyping, and augmented clinical decision support; (3) improve education to providers, staff, and patients/care partners; (4) identify best practices to improve relevant outcomes; (5) validate quality indicators; and (6) assess the effect of social determinants of health on outcomes. We urge all stakeholders involved in the process of AKI-D care to align goals and work together to fill knowledge gaps and optimize the care to this highly vulnerable patient population.
AB - Background Up to one third of survivors of AKI that required dialysis (AKI-D) during hospitalization remain dialysis dependent at hospital discharge. Of these, 20%-60%, depending on the clinical setting, eventually recover enough kidney function to stop dialysis, and the remainder progress to ESKD. Methods To describe the challenges facing those still receiving dialysis on discharge, the AKINow Committee conducted a group discussion comprising 59 participants, including physicians, advanced practitioners, nurses, pharmacists, and patients. The discussion was framed by a patient who described gaps in care delivery at different transition points and miscommunication between care team members and the patient. Results Group discussions collected patient perspectives of (1) being often scared and uncertain about what is happening to and around them and (2) the importance of effective and timely communication, a comfortable physical setting, and attentive and caring health care providers for a quality health care experience. Provider perspectives included (1) the recognition of the lack of evidence-based practices and quality indicators, the significant variability in current care models, and the uncertain reimbursement incentives focused on kidney recovery and (2) the urgency to address communication barriers among hospital providers and outpatient facilities. Conclusions The workgroup identified key areas for future research and policy change to (1) improve communication among hospital providers, dialysis units, and patients/care partners; (2) develop tools for risk classification, subphenotyping, and augmented clinical decision support; (3) improve education to providers, staff, and patients/care partners; (4) identify best practices to improve relevant outcomes; (5) validate quality indicators; and (6) assess the effect of social determinants of health on outcomes. We urge all stakeholders involved in the process of AKI-D care to align goals and work together to fill knowledge gaps and optimize the care to this highly vulnerable patient population.
KW - AKI
UR - http://www.scopus.com/inward/record.url?scp=85186323528&partnerID=8YFLogxK
U2 - 10.34067/KID.0000000000000332
DO - 10.34067/KID.0000000000000332
M3 - Article
C2 - 38055734
AN - SCOPUS:85186323528
SN - 2641-7650
VL - 5
SP - 274
EP - 284
JO - Kidney360
JF - Kidney360
IS - 2
ER -